Breaking News

Vitrian Invests in AmplifyBio’s Ohio Biomanufacturing Facility

Commits to support biomanufacturing in Central Ohio.

Author Image

By: Charlie Sternberg

Associate Editor

Vitrian, an end-to-end provider of investment capital and capacity-building services for biomanufacturing, has closed a $50 million investment, with the ability to scale to $65 million, into AmplifyBio’s Manufacturing Enablement Center (AMEC) in New Albany, Ohio, as part of a larger commitment to support biomanufacturing in Central Ohio.   AmplifyBio is an advanced therapy CRO and CDMO offering a full range of drug development and manufacturing services.   Located in the heart of Central Ohi...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters